Schwarz turns to drug delivery
German generics producer Schwarz Pharma has licensed rights to a drug delivery technology developed by US company Lipocine, to revamp its pipeline in the face of competitive threats to its biggest product.
Archives for May 25, 2004
New approach to HIV treatment
Researchers in the US are testing a new way to treat HIV by destroying the virus as it enters host cells. The treatment is based on the genetic manipulation of the immune cells that HIV infects to enable them to destroy the virus.
Swedish discovery tools firm raises €5.8m
Swedish drug discovery technology company Cellectricon has raised a total of SEK 53 million (€5.8 million) following the completion of its latest Series B financing round, writes Wai Lang Chu.
IntroTech pushes temperature range of monitor
An unnamed European pharmaceutical company is using time temperature indicators (TTI) to ensure heart valves used in human heart transplants are kept at the optimum temperature.
Banner launches chewable gel technology
Banner Pharmaceuticals has developed a new oral delivery formulation that is designed to make it easier to dose drugs to children and the elderly and to take medications on the go, writes Phil Taylor.
Ajanta may be API supplier again
India's Ajanta Pharma has said that it may re-enter the market for bulk manufacture of active pharmaceutical ingredients (APIs), despite pulling out of the sector in the late 1990s.
Coating tech licensed for improved stents
Occam International of the Netherlands has licensed its coating technology to Xtent, a company specialising in the development of cardiovascular stents that deliver drugs directly into the blood vessels.